Healthy volunteers help test new Drug's safety
NCT ID NCT04155567
First seen Nov 20, 2025 · Last updated Apr 28, 2026 · Updated 17 times
Summary
This early-stage study tested a drug called TAK-123 in 10 healthy Japanese men to see how the body processes it and if it causes side effects. The goal was to gather safety and drug-level information, not to treat any disease. Participants received a single intravenous dose and were monitored for a short time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sekino Clinical Pharmacology Clinic
Toshima-ku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.